Vedamruth Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 95.67%
- Profit Growth 86.88%
- Ebitda -32.77%
- Net Worth -9.63%
- Total Assets 18.12%
About Vedamruth Health Sciences
Vedamruth Health Sciences Private Limited (VHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2007 and has a history of 17 years and eight months. Its registered office is in Aluva, Kerala.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anup Chandran, Putyhanparambil Chandran, Subhashini Gangadharan, and One other member serve as directors at the Company.
Company Details
- LocationAluva, Kerala
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24233KL2007PTC020818
- Company No.
020818
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 May 2007
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Vedamruth Health Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Chandran  | Managing Director | 18-May-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anup Chandran | Director | 18-May-2007 | Current |
| Putyhanparambil Chandran | Director | 18-May-2007 | Current |
| Subhashini Gangadharan | Director | 18-May-2007 | Current |
Financial Performance of Vedamruth Health Sciences.
Vedamruth Health Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 95.67% increase. The company also saw a substantial improvement in profitability, with a 86.88% increase in profit. The company's net worth dipped by a decrease of 9.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vedamruth Health Sciences?
In 2017, Vedamruth Health Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vedamruth Health Sciences?
Unlock and access historical data on people associated with Vedamruth Health Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vedamruth Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vedamruth Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.